club.castorsbraine.be
Régionale 2 Dames – Série A | Royal Castors Braine
http://club.castorsbraine.be/team/regionale-2-dames
Régionale 2 Dames - Série A. Provinciale 2 Dames - Série A. Provinciale 2 Dames - Série C. Provinciale 2 Hommes - Série A. Provinciale 3 Hommes - Série A. Juniors AWBB - U21B. Cadets AWBB - U18A. Minimes Filles AWBB - U16B. Minimes Provinciales - U16. Minimes Provinciaux A - HU16B. Minimes Provinciaux B - HU16C. Pupilles Régionales - U14A. Pupilles Provinciales - U14. Pupilles Garçons AWBB - U14A. Pupilles Garçons Provinciaux - HU14B. Benjamins A - U12B. Benjamins B - U12C. Benjamins C - U12D. Recrutemen...
club.castorsbraine.be
Evènements | Royal Castors Braine
http://club.castorsbraine.be/newscat/event
Régionale 2 Dames - Série A. Provinciale 2 Dames - Série A. Provinciale 2 Dames - Série C. Provinciale 2 Hommes - Série A. Provinciale 3 Hommes - Série A. Juniors AWBB - U21B. Cadets AWBB - U18A. Minimes Filles AWBB - U16B. Minimes Provinciales - U16. Minimes Provinciaux A - HU16B. Minimes Provinciaux B - HU16C. Pupilles Régionales - U14A. Pupilles Provinciales - U14. Pupilles Garçons AWBB - U14A. Pupilles Garçons Provinciaux - HU14B. Benjamins A - U12B. Benjamins B - U12C. Benjamins C - U12D. Si ce prob...
investors.mithra.com
What is Estetrol? - Mithra Pharmaceuticals Investors Website
http://investors.mithra.com/en/what-is-estetrol
Phone: 32 (0)4 349 28 22. Fax: 32 (0)4 349 28 21. Subscribe to our Mailing List.
investors.mithra.com
Press Releases - Mithra Pharmaceuticals Investors Website
http://investors.mithra.com/en/press-releases
Mithra Reports 2016 Annual Results. Mithra Signs a Binding Term Sheet with the Japanese Leader in Women’s Health Fuji Pharma to Commercialize Donesta in Japan and ASEAN. Mithra Agrees Exclusive Long-Term License and Supply Agreement with Mayne Pharma to Commercialize Myring in the US. Mithra Granted EUR 1.9 million in Non-Dilutive Funding. Mithra Completes Recruitment for European Phase III Estelle Study. Mithra Strengthens Position in the Belgian Contraception Market. Page 1 of 8. Fax: 32 (0)4 349 28 21.
investors.mithra.com
Corporate Governance - Mithra Pharmaceuticals Investors Website
http://investors.mithra.com/en/corporate-governance
Chairman, Non-executive Director. Mr Coucke holds a degree in Pharmacy (University Ghent) and an MBA (Vlerick Management School, Ghent). He is the founder of Omega Pharma. Until September 2006, he held both the position of CEO and Chairmen of Omega Pharma. After the acquisition of Omega Pharma by Perrigo, he became Executive VP of Perrigo and CEO of Omega Pharma. François has been elected the French speaking 2011 Manager of the year by the Belgian business magazine Trends/Tendances. Mr Platieau holds a d...
investors.mithra.com
Webinar (FR) - Mithra Pharmaceuticals Investors Website
http://investors.mithra.com/en/webinar-fr
Phone: 32 (0)4 349 28 22. Fax: 32 (0)4 349 28 21. Subscribe to our Mailing List.
investors.mithra.com
Financial Information - Mithra Pharmaceuticals Investors Website
http://investors.mithra.com/en/financial-information
Annual Report 2016 (available online). Ordinary General Shareholders’ Meeting. Half Year 2017 Results. Half Year 2016 Results (full report). Half Year 2015 Results (Full report). Phone: 32 (0)4 349 28 22. Fax: 32 (0)4 349 28 21. Subscribe to our Mailing List.
investors.mithra.com
Share Price - Mithra Pharmaceuticals Investors Website
http://investors.mithra.com/en/share-price
00,00 ( 0%). François Fornieri holds his shareholding partially through Mithra Participations (a société civile de droit commun), of which he is the director. Marc Coucke holds his shareholding partially through Alychlo NV and Mylecke Management Art & Invest NV, which he both controls. Bart Versluys holds his shareholding through Scorpiaux BVBA and Versluys Bouwgroep BVBA, which he both controls. Total number of voting rights (denominator). All relating to ordinary shares). Marc Coucke Alychlo NV.
SOCIAL ENGAGEMENT